Evidence map›Paper›PMID 21819630›Full record

ReviewRadiation oncology (London, England)2011

Pure seminoma: a review and update.

Noureddine Boujelbene, Adrien Cosinschi, Nadia Boujelbene, Kaouthar Khanfir, Shushila Bhagwati, Eveleyn Herrmann, Rene-Olivier Mirimanoff, Mahmut Ozsahin, Abderrahim Zouhair

Abstract readReview
In one paragraph

Review in Radiation oncology (London, England), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Article
  2. Article
  3. Neoplasia in the dromedary camel: a review (Frontiers in veterinary science · 2025
    Review
  4. Article
  5. Article
  6. The fate of germ cells in cryptorchid testis.Frontiers in endocrinology · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. True hermaphroditism with seminoma: A case report.Molecular and clinical oncology · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Noureddine BoujelbeneDepartment of Radiation Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Bugnon 46, CH-1011 Lausanne, Switzerland. nboujelbene@gmail.com
Adrien Cosinschi
Nadia Boujelbene
Kaouthar Khanfir
Shushila Bhagwati
Eveleyn Herrmann
Rene-Olivier Mirimanoff
Mahmut Ozsahin
Abderrahim Zouhair

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pure seminoma is a rare pathology of the young adult, often discovered in the early stages. Its prognosis is generally excellent and many therapeutic options are available, especially in stage I tumors. High cure rates can be achieved in several ways: standard treatment with radiotherapy is challenged by surveillance and chemotherapy. Toxicity issues and the patients' preferences should be considered when management decisions are made. This paper describes firstly the management of primary seminoma and its nodal involvement and, secondly, the various therapeutic options according to stage.

Indexed as

AdolescentAdultBiopsyClinical Trials as TopicCombined Modality TherapyHumansLymphatic MetastasisMaleMedical OncologyNeoplasm StagingPrognosisRadiotherapyRecurrenceSeminomaTesticular NeoplasmsTreatment Outcome

Identifiers

PMID21819630
PMCPMC3163197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.